This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Treatments

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

NIH Urges You To Make a Plan To Prevent Diabetes, Complications

Posted: Wednesday, November 02, 2011

In observance of National Diabetes Month and World Diabetes Day on Nov. 14, the National Institutes of Health urges people to set goals and make plans to prevent diabetes and diabetes-related complications.

Diabetes Patients Have Double the Risk for Hepatitis B Infection

Posted: Tuesday, November 01, 2011

The CDC held a hearing on a recommendation that patients with diabetes receive immunization with the hepatitis B vaccine.
Results from CDC investigations identified inadequately cleaned blood glucose monitors as a major route of hepatitis B virus transmission among patients with diabetes.

Diabetes Medication Compliance a Major U.S. Issue

Posted: Sunday, October 23, 2011

We need to do a better job. Research by the New England Healthcare Institute shows that patients who don't take their medications as prescribed, cost the U.S. health care system an estimated $290 billion in avoidable medical spending each year.

FDA Approves Diabetes and Cholesterol-Lowering Drug Combo: Juvisync®

Posted: Sunday, October 09, 2011

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.

Intensified Treatment with Basal Insulin Improves Control and Weight Loss

Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes

Posted: Saturday, September 24, 2011

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone.

EASD: Twice-Daily Aspirin Betters Platelet Inhibition for People with Diabetes

Posted: Monday, September 19, 2011

Twice-daily aspirin administration, but not a once-daily doubling of the dose, appears to provide good inhibition of platelet cyclooxygenase (COX)-1 in diabetic patients who have rapid recovery of COX-1 activity, and might enhance cardiovascular protection.

EASD: First Injection-free Once-A-Year GLP-1

Posted: Sunday, September 18, 2011

ITCA 650, injection-free continuous delivery of GLP-1 therapy, demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI AEs typically associated with this class.

Diabetes Treatment Should Be Gender-based

Posted: Saturday, August 20, 2011

Data on 3,000 participants found a significant difference in lipid, amino acid and other metabolites between males and females. The findings underscore the need for gender-specific treatments for diabetes and other metabolic disorders.

New Technology Helps Patients Manage Diabetes

Posted: Monday, August 08, 2011

An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study.